-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
THC Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2019 to Q1 2024.
- THC Therapeutics, Inc. Cost of Revenue for the quarter ending April 30, 2024 was $0.000.
- THC Therapeutics, Inc. Cost of Revenue for the twelve months ending April 30, 2024 was $0.000.
- THC Therapeutics, Inc. annual Cost of Revenue for 2023 was $0.000.
- THC Therapeutics, Inc. annual Cost of Revenue for 2022 was $0.000.
- THC Therapeutics, Inc. annual Cost of Revenue for 2021 was $0.000.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)